Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 29, 2012

View Archived Issues

Chugai Pharmaceutical reflects on milestones of 2011

Modified gold nanoparticles display potent anticoagulant activity

Phase II trial assesses safety paclitaxel/everolimus combination in advanced urothelial cancer

New cognition-enhancing serotonin 5-HT6 receptor antagonist discovered at Cephalon

AnaptysBio describes new antibodies targeting IL-17

Merck & Co. patents novel products with potential to prevent herpes zoster

Novel 5-lipoxygenase inhibitors disclosed by Ranbaxy Laboratories

Medexis reports new products with potential to treat cancer

New cyclopropylamine derivatives designed at Oryzon Genomics

Wakunaga and NeuGen Pharma present new agents for neurological disorders

Zalicus compounds show promise as therapies for absence seizures

Selventa enters new collaboration

Alimera Sciences and pSivida provide update on Iluvien

BioDelivery Sciences and FDA agree on BEMA-buprenorphine/naloxone development plan

Proteonomix gives update on UMK-121 study

Bioheart selects site for ANGEL trial

Phase III trials of 6-month anticancer depot begin in Japan

OncoSec initiates treatment in phase II trial in metastatic melanoma

Antisense Therapeutics to form joint venture for development of ATL-1102

Lundbeck acquires remaining rights to ischemic stroke treatment candidate

New RaQualia product set to enter clinical development

FDA revises labeling for statins

Samsung Biologics and Biogen Idec form joint venture

Abbott enters global agreement for novel JAK1 inhibitor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...